By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pluristem Therapeutics 



New York  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Pluristem Therapeutics (PSTI) And Hadassah Medical Center Will Collaborate To Study Potential Of PLX-RAD Cells To Improve Bone Marrow And Umbilical Cord Blood Transplant Outcomes 12/4/2014 10:33:43 AM
Pluristem Therapeutics (PSTI) Granted Patent In Singapore For Its 3D Cell Expansion Technology 12/1/2014 10:08:14 AM
Pluristem Therapeutics (PSTI)'s Dr. Ohad Karnieli To Present At Two Upcoming Scientific Conferences 11/26/2014 11:41:25 AM
Presentations To Focus On Pluristem Therapeutics (PSTI)'s Industry-Leading Expertise In 3D Cell Culturing And Cell Expansion Technologies 11/25/2014 9:41:58 AM
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014 7:33:41 AM
Pluristem Therapeutics (PSTI) CEO Zami Aberman To Present At Two Regenerative Medicine Conferences In London On November 12 And 13, 2014 11/10/2014 10:02:33 AM
Case Western Reserve University To Study Pluristem Therapeutics (PSTI)'s PLX-RAD Cells In Umbilical Cord Blood Transplants For The Treatment Of Blood Cancers And Genetic Diseases 10/27/2014 7:43:12 AM
Pluristem Therapeutics (PSTI) Advances Its Second Major Cell Therapy Product Line From Development To Large-Scale Manufacturing 10/21/2014 6:19:03 AM
Pluristem Therapeutics (PSTI) Wins Cell Therapy Patent Case In Europe; European Patent Office Confirms Validity Of Amended Claims 10/7/2014 7:30:12 AM
Coverage Initiation Report Focuses On Pluristem Therapeutics (PSTI) 10/3/2014 11:49:00 AM
12345678910...
//-->